Freff, Jana
Schwarte, Kathrin
Bröker, Lisa
Bühlmeier, Judith
Kraft, Isabelle
Öztürk, Dana
Hinney, Anke
Arolt, Volker
Dannlowski, Udo
Romer, Georg
Baune, Bernhard T.
Hebebrand, Johannes
Föcker, Manuel
Alferink, Judith
Funding for this research was provided by:
DFG-FOR2107 (AL1145/5-2)
DFG (HI865/2-1)
Landesprogramm für Geschlechtergerechte Hochschulen
Intramural funds of the University Hospital Essen
DFG EXC 1003 Cells in Motion–Cluster of Excellence (FF-2014-01)
Projekt DEAL
Article History
Received: 7 August 2020
Accepted: 15 December 2020
First Online: 13 January 2021
Competing interests
: JA gave presentations for Servier. VA is member of advisory boards and/or gave presentations for the following companies: Astra-Zeneca, Eli Lilly, Janssen-Organon, Lundbeck, Otsuka, Servier, and Trommsdorff. BTB is member of advisory boards and/or received speaker/consultation fees from AstraZeneca, Lundbeck, Pfizer, Takeda, Servier, Bristol Myers Squibb, Otsuka, and Janssen-Cilag. All other authors declare that they have no conflict of interest.